Howard Horn

Insider Reports History

Entity
Individual
Location
C/O Vir Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Horn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Chief Financial Officer Common Stock 92.3K $4.87M $52.76 Oct 10, 2024 Direct
Vir Biotechnology, Inc. CFO Common Stock 231K $353K $1.53 Feb 23, 2023 Direct
Ultragenyx Pharmaceutical Inc. Chief Financial Officer Stock Option (Right to Buy) 34.2K Mar 1, 2024 Direct

Insider Reports Filed by Howard Horn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Oct 10, 2024 1 -$394K 4 Oct 11, 2024 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Oct 9, 2023 2 $0 4 Oct 10, 2023 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Oct 9, 2023 0 $0 3 Oct 10, 2023 Chief Financial Officer
VIR Vir Biotechnology, Inc. Feb 23, 2023 1 -$58.4K 4 Feb 24, 2023 CFO
VIR Vir Biotechnology, Inc. Feb 17, 2023 1 -$61.3K 4 Feb 21, 2023 CFO
VIR Vir Biotechnology, Inc. Feb 22, 2022 2 $0 4 Feb 24, 2022 CFO
VIR Vir Biotechnology, Inc. Feb 17, 2022 1 -$76.4K 4 Feb 22, 2022 CFO